Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 16 - Number 7
Is there a Role for Bevacizumab in Non-Glial Tumors?
, 16(7): 684 - 688Elisa Trevisan, Luca Bertero, Michela Magistrello, Roberta Ruda and Riccardo Soffietti
DOI: 10.2174/1389450116666150325230810
Is there a Role for Bevacizumab in Non-Glial Tumors?
Mechanisms of bacterial acetohydroxyacid synthase (ahas) and specific inhibitors of Mycobacterium tuberculosis ahas as potential drug candidates against tuberculosis
, 16(7): 689 - 699Kunal Gokhale and Bhargav Tilak
DOI: 10.2174/1389450116666150416115547
Mechanisms of bacterial acetohydroxyacid synthase (ahas) and specific inhibitors of Mycobacterium tuberculosis ahas as potential drug candidates against tuberculosis
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation
, 16(7): 700 - 710Erin E. Witalison, Paul R. Thompson and Lorne J. Hofseth
DOI: 10.2174/1389450116666150202160954
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
, 16(7): 711 - 734Imran Ali, Mohammad Nadeem Lone, Zeid A. Al-Othman, Abdulrahman Al-Warthan and Mohd. Marsin Sanagi
DOI: 10.2174/1389450116666150309115922
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Selective Modulators of α5-Containing GABAA Receptors and their Therapeutic Significance
, 16(7): 735 - 746Ming Shiuan Soh and Joseph W. Lynch
DOI: 10.2174/1389450116666150309120235
Selective Modulators of α5-Containing GABAA Receptors and their Therapeutic Significance
Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
, 16(7): 747 - 756Francesca Scicchitano, Andrew Constanti, Rita Citraro, Giovambattista De Sarro and Emilio Russo
DOI: 10.2174/1389450116666150330114850
Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets
, 16(7): 757 - 770Annalisa Crema, Antonio Ponzetto, Massimo Clementi and Guido Carloni
DOI: 10.2174/1389450116666150213111603
Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets
Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis
, 16(7): 771 - 775Sameer Mohammad
DOI: 10.2174/1389450116666150408103557
Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net